Herpes Labialis Clinical Trial
Official title:
A Multicenter, Open-label, Single-arm Study to Evaluate the Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis
This study will assess the safety, tolerability of a single 1500 mg dose of famciclovir in 50 adolescents with recurrent herpes labialis. Eight of the 50 adolescents will also participate in the pharmacokinetics (PK) assessment of famciclovir single 1500 mg dose
Uncontrolled study ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02483182 -
Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores
|
Phase 2 | |
| Completed |
NCT00297011 -
Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis
|
Phase 2 | |
| Completed |
NCT03310294 -
Immune Evidence to the Consumption of Lactobacillus GG and FOS Consumption in Patients With Herpes Labialis
|
N/A | |
| Terminated |
NCT04539483 -
Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 1 Infection
|
Phase 2 | |
| Completed |
NCT02265913 -
Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis
|
Phase 3 | |
| Completed |
NCT01971385 -
Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis
|
Phase 1 | |
| Active, not recruiting |
NCT01695187 -
NB-001 Treatment of Recurrent Herpes Labialis
|
Phase 3 | |
| Completed |
NCT00375570 -
Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents
|
Phase 3 | |
| Completed |
NCT02871492 -
Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial Herpes
|
Phase 2 | |
| Completed |
NCT01484067 -
Study of a Cold Sore Patch for the Treatment of Herpes Labialis
|
N/A | |
| Completed |
NCT00769314 -
Phase 3 Clinical Study for the Treatment of Cold Sore
|
Phase 3 | |
| Completed |
NCT01574612 -
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
|
Phase 3 | |
| Completed |
NCT03661541 -
Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)
|
Phase 1 | |
| Recruiting |
NCT01306084 -
Viral Infections in Healthy and Immunocompromised Hosts
|
||
| Terminated |
NCT03521479 -
A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
|
Phase 2 | |
| Terminated |
NCT00913692 -
A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis
|
Phase 2 | |
| Completed |
NCT02207881 -
A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis
|
Phase 2 | |
| Completed |
NCT01653509 -
An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode
|
Phase 1 | |
| Completed |
NCT00361881 -
Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis
|
Phase 3 | |
| Recruiting |
NCT02582086 -
Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis
|
N/A |